PHA-848125-d3 is labelled PHA-848125 (P294490) which is a cyclin dependent kinase (CDK) inhibitor. Oral PHA-848125 showed antitumor activity via dual targeting of cyclin-dependent kinase and tropomyosin receptor kinase families in human carcinoma cell and xenografted mouse model of carcinoma. Molecular Formula: C25H29D3N8O Molecular Weight: 463.59 Storage and Stability: Store at -20C. For maximum recovery of product, centrifuge the original vial prior to removing the cap.
Molecular Weight:
463.59
* VAT and and shipping costs not included. Errors and price changes excepted
